Literature DB >> 11850280

International interlaboratory quality control program for measurement of antiretroviral drugs in plasma.

Rob E Aarnoutse1, Corrien P W G M Verweij-van Wissen, Eleonora W J van Ewijk-Beneken Kolmer, Eveline W Wuis, Peter P Koopmans, Yechiel A Hekster, David M Burger.   

Abstract

An international interlaboratory quality control program for measurement of antiretroviral drugs was initiated. The first round was confined to protease inhibitors and showed large variability in the performance of participating laboratories. The results demonstrate the need for and utility of an ongoing quality control program in this area of bioanalysis.

Mesh：

Substances：

Year:  2002        PMID： 11850280      PMCID： PMC127484          DOI： 10.1128/AAC.46.3.884-886.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

Review 1.  High-performance liquid chromatography of HIV protease inhibitors in human biological matrices.

Authors:  R E Aarnoutse; C P Verweij-van Wissen; W J Underberg; J Kleinnijenhuis; Y A Hekster; D M Burger
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-11-25

2.  Proficiency testing programs--promises, progress, and problems. A 40-year prospective.

Authors:  R H Laessig; S S Ehrmeyer
Journal:  Arch Pathol Lab Med       Date:  1988-04       Impact factor: 5.534

Review 3.  Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection.

Authors:  D J Back; S H Khoo; S E Gibbons; M G Barry; C Merry
Journal:  Ther Drug Monit       Date:  2000-02       Impact factor: 3.681

4.  Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.

Authors:  P W Hugen; C P Verweij-van Wissen; D M Burger; E W Wuis; P P Koopmans; Y A Hekster
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1999-04-30

Review 5.  Proficiency testing in laboratory medicine: uses and limitations.

Authors:  S Shahangian
Journal:  Arch Pathol Lab Med       Date:  1998-01       Impact factor: 5.534

Review 6.  Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection.

Authors:  M Barry; F Mulcahy; C Merry; S Gibbons; D Back
Journal:  Clin Pharmacokinet       Date:  1999-04       Impact factor: 6.447

Review 7.  Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors.

Authors:  E P Acosta; T N Kakuda; R C Brundage; P L Anderson; C V Fletcher
Journal:  Clin Infect Dis       Date:  2000-06       Impact factor: 9.079
  7 in total
  12 in total

1.  Quality assurance program for clinical measurement of antiretrovirals: AIDS clinical trials group proficiency testing program for pediatric and adult pharmacology laboratories.

Authors:  Diane T Holland; Robin DiFrancesco; Judith Stone; Fayez Hamzeh; James D Connor; Gene D Morse
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Antiretroviral therapeutic drug monitoring in Canada: current status and recommendations for clinical practice.

Authors:  Niamh Higgins; Alice Tseng; Nancy L Sheehan; Charles J L la Porte
Journal:  Can J Hosp Pharm       Date:  2009-11

3.  Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor.

Authors:  Joel G R Weaver; Agathe Tarze; Tia C Moffat; Morgane Lebras; Aurelien Deniaud; Catherine Brenner; Gary D Bren; Mario Y Morin; Barbara N Phenix; Li Dong; Susan X Jiang; Valerie L Sim; Bogdan Zurakowski; Jessica Lallier; Heather Hardin; Peter Wettstein; Rolf P G van Heeswijk; Andre Douen; Romano T Kroemer; Sheng T Hou; Steffany A L Bennett; David H Lynch; Guido Kroemer; Andrew D Badley
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

4.  International interlaboratory proficiency testing program for measurement of azole antifungal plasma concentrations.

Authors:  Roger J M Brüggemann; Daan J Touw; Rob E Aarnoutse; Paul E Verweij; David M Burger
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

Review 5.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

6.  Can therapeutic drug monitoring improve pharmacotherapy of HIV infection in adolescents?

Authors:  Natella Y Rakhmanina; John N van den Anker; Steven J Soldin; Ron H van Schaik; Nick Mordwinkin; Michael N Neely
Journal:  Ther Drug Monit       Date:  2010-06       Impact factor: 3.681

7.  Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): a multicenter clinical trial.

Authors:  Robin DiFrancesco; Susan Rosenkranz; A Lisa Mukherjee; Lisa M Demeter; Hongyu Jiang; Robert DiCenzo; Carrie Dykes; Alex Rinehart; Mary Albrecht; Gene D Morse
Journal:  Ther Drug Monit       Date:  2010-08       Impact factor: 3.681

8.  Clinical pharmacology quality assurance program: models for longitudinal analysis of antiretroviral proficiency testing for international laboratories.

Authors:  Robin DiFrancesco; Susan L Rosenkranz; Charlene R Taylor; Poonam G Pande; Suzanne M Siminski; Richard W Jenny; Gene D Morse
Journal:  Ther Drug Monit       Date:  2013-10       Impact factor: 3.681

Review 9.  Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Authors:  Rob E Aarnoutse; Jonathan M Schapiro; Charles A B Boucher; Yechiel A Hekster; David M Burger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.

Authors:  Elinore F McCance-Katz; David E Moody; Gene D Morse; Qing Ma; Robin DiFrancesco; Gerald Friedland; Patricia Pade; Petrie M Rainey
Journal:  Drug Alcohol Depend       Date:  2007-07-23       Impact factor: 4.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.